Skip to main content
. 2025 Jul 2;17(13):2220. doi: 10.3390/cancers17132220
ANLN Actin-binding protein
ALKBH5 AlkB homolog 5
AUC Area under the ROC curve
PD-L1 Programmed death-ligand 1
CTLA4 Cytotoxic T-lymphocyte-associated protein 4
DEGs Differentially expressed genes
ECL Enhanced chemiluminescence
EdU Ethynyl-2′-deoxyuridine
FPKM Fragments per kilobase of transcript per million mapped reads
FTO Fat mass and obesity-associated protein
GAL-9 Galectin-9
GEO Gene Expression Omnibus
HCC Hepatocellular carcinoma
HNRNPC Heterogeneous nuclear ribonucleoprotein C
HR Hazard ratio
ICGC International Cancer Genomics Consortium
ICIs Immune checkpoint inhibitors
IPS Immunophenotype score
LAG-3 lymphocyte-activating 3
LASSO Least absolute shrinkage and selection operator
m6A N6-methyladenosine
METTL Methyltransferase-like
mRNAsi mRNA stemness index
NK cells Natural killer cells
OS Overall survival
PCA Principal component analysis
PDCD1 Programmed cell death protein 1
RBM15 RNA-binding motif protein 15
ROC Receiver operating characteristic
shRNA Short hairpin RNA
TCGA The Cancer Genome Atlas
TIDE Tumor immune dysfunction and exclusion
TIGIT T cell immunoreceptor with Ig and ITIM domains
TIM-3 T cell immunoglobulin and mucin-domain containing-3
TMB Tumor mutation burden
TPM Transcripts per million kilobase
UMAP Uniform Manifold Approximation and Projection
VIRMA Vir-Like m6A Methyltransferase Associated protein
WTAP Wilms tumor 1-associating protein
YTH YT521-B homology
ZC3H13 Zinc finger CCCH-type containing 13